Enhanced antibacterial activity of substituted derivatives of ncr169c peptide

HIGHLIGHTS

• who: Dian H. O. Howan et al. from the Department of Medical Chemistry, Albert Szent-Gyu00f6rgyi Medical School, University of have published the article: Enhanced Antibacterial Activity of Substituted Derivatives of NCR169C Peptide, in the Journal: (JOURNAL) of 25/01/2023
• what: The authors show that NCR169C17-38 and its various substituted derivatives are also able to kill ESKAPE pathogens such as Enterococcus faecalis Staphylococcus aureus Klebsiella pneumoniae Acinetobacter baumannii Pseudomonas aeruginosa and Escherichia coli. The authors investigated and demonstrated the antibacterial activity of NCR169C17-38, against various Gram-positive and Gram-negative ESKAPE pathogenic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.